Highlights PAVmed Inc.

Equities

PAVM

US70387R4039

Market Closed - Nasdaq Other stock markets 01:30:00 09/05/2024 am IST			5-day change	1st Jan Change
2.2 ^USD	-3.08%		-4.76%	-46.60%

07/05	Pavmed Inc. Appoints Dennis Matheis to Board of Directors	CI
27/03	Transcript : PAVmed Inc., Q4 2023 Earnings Call, Mar 27, 2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PAVmed Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/03	CI
PAVmed Inc. Launches Incubator to Advance Existing Pipeline Technologies including PortIO, EsoCure and CarpX	21/03	CI
Lucid Diagnostics Inc. and Pavmed Inc. Announces Peer-Reviewed Publication of Positive Results from Three Clinical Utility Studies	12/12	CI
PAVmed Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Pavmed Inc. Releases Positive Data from First Prospective Clinical Utility Study of EsoGuard® Esophageal Pre Cancer Detection	07/23/07	CI
PAVmed Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15	CI
PAVmed Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	16/23/16	CI
PAVmed : 10-K Filing FY 2022	14/23/14	PU
PAVmed Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14/23/14	CI
PAVmed Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14/23/14	CI
PAVMED INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	14/23/14	AQ
PAVmed Inc. Partners with Novosound Ltd on Ultrasound Imaging Technology	22/22/22	CI
PAVmed Q3 Net Loss Widens, Revenue Declines	16/22/16	MT
PAVmed Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI
PAVmed Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/22/16	CI
PAVmed Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	13/22/13	CI
PAVMED INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	06/22/06	AQ
PAVmed : Conference Call Transcript FY 2021	30/22/30	PU
PAVmed Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	30/22/30	CI
PAVmed Inc. Subsidiary Lucid Diagnostics Announces Launch of VA Esoguard® Study	24/22/24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights PAVmed Inc.

Equities

PAVM

US70387R4039

Highlights

Filters